173 related articles for article (PubMed ID: 6782500)
1. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
Köves K; Marton J; Molnár J; Halász B
Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
[TBL] [Abstract][Full Text] [Related]
2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
Vermes I; Szontágh L; Telegdy G
Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
[TBL] [Abstract][Full Text] [Related]
4. Reversal of beta-endorphin-induced blockade of ovulation and luteinizing hormone surge with prostaglandin E2.
Leadem CA; Kalra SP
Endocrinology; 1985 Aug; 117(2):684-9. PubMed ID: 3160573
[TBL] [Abstract][Full Text] [Related]
5. Effect of a met-enkephalin analogue and naloxone infusion on gonadotrophin secretion in man.
Delitala G; Giusti M; Devilla L; Mazzocchi G; Lotti G; Giordano G
Acta Eur Fertil; 1981 Sep; 12(3):287-8. PubMed ID: 6803502
[No Abstract] [Full Text] [Related]
6. Increase of plasma ACTH in the rat following the administration of D-met2-pro5-enkephalinamide.
Reina RA; Costa G; Scoto GM; Spadaro C; Spampinato S; Ferri S
Pharmacol Res Commun; 1980 May; 12(5):479-82. PubMed ID: 6108573
[No Abstract] [Full Text] [Related]
7. Effect of Met-enkephalin and (D-Met2,Pro5)-enkephalinamide on the adenylate cyclase activity of rat brain.
Wollemann M; Szebeni A; Bajusz S; Gráf L
Neurochem Res; 1979 Oct; 4(5):627-31. PubMed ID: 492449
[TBL] [Abstract][Full Text] [Related]
8. Morphine inhibition of the preovulatory surges of plasma luteinizing hormone and follicle stimulating hormone in the rat.
Pang CN; Zimmermann E; Sawyer CH
Endocrinology; 1977 Dec; 101(6):1726-32. PubMed ID: 338290
[No Abstract] [Full Text] [Related]
9. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
Székely JI; Miglécz E; Rónai AZ
Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
Miglécz E; Székely JI; Dunai-Kovács Z
Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
[TBL] [Abstract][Full Text] [Related]
11. Mesencephalic sites of action of an enkephalin analogue (D-Met2, Pro5)-enkephalinamide and naloxone on the anterior pituitary of male rats.
Molnár J; Halász B
Brain Res; 1991 Nov; 563(1-2):270-2. PubMed ID: 1786539
[TBL] [Abstract][Full Text] [Related]
12. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
Rónai AZ; Berzétei IP; Bajusz S; Székely JI
J Pharm Pharmacol; 1981 Aug; 33(8):534-5. PubMed ID: 6115930
[No Abstract] [Full Text] [Related]
13. Cardiovascular effects of a potent opioid peptide, (D-Met2, Pro5)-enkephalinamide.
Jaszlits L; Kósa E; Tardos L; Danitz B; Kauthny K; Székely JI
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):91-103. PubMed ID: 7165424
[TBL] [Abstract][Full Text] [Related]
14. Effect of opioid peptides on gonadotrophin secretion.
Motta M; Martini L
Acta Endocrinol (Copenh); 1982 Mar; 99(3):321-5. PubMed ID: 6803482
[TBL] [Abstract][Full Text] [Related]
15. Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.
Környei JL; Vértes Z; Kovács KA; Göcze PM; Vértes M
Cell Prolif; 2003 Jun; 36(3):151-63. PubMed ID: 12814431
[TBL] [Abstract][Full Text] [Related]
16. The role of endogenous opioids in the blockade of reproductive function in the rat following exposure to acute stress.
Hulse GK; Coleman GJ
Pharmacol Biochem Behav; 1983 Nov; 19(5):795-9. PubMed ID: 6685880
[TBL] [Abstract][Full Text] [Related]
17. The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone.
Grossman A; Moult PJ; Gaillard RC; Delitala G; Toff WD; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1981 Jan; 14(1):41-7. PubMed ID: 6784982
[TBL] [Abstract][Full Text] [Related]
18. Behavioral activating effects of opiates and opioid peptides.
Browne RG; Segal DS
Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
[TBL] [Abstract][Full Text] [Related]
19. Effect of naloxone and D-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain.
Vértes Z; Melegh G; Vértes M; Kovács S
Life Sci; 1982 Jul; 31(2):119-26. PubMed ID: 7121198
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice.
Ueda H; Amano H; Shiomi H; Takagi H
Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
